Data / Form D filings / Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.: Form D filings
Voyager Therapeutics, Inc., a biotechnology company in Lexington, MA, filed 3 Form D notices with the SEC between 2015 and 2024. The latest, on January 17, 2024, reports $20 million sold of a $20 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 75 HAYDEN AVENUE, Lexington, MA, 02421
- Phone
- (857) 259-5340
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1640266
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | New notice | $19,999,999 | $19,999,999 | 1 | Jan 3, 2024 | sec.gov | |
| Mar 3, 2023 | New notice | $39,032,821 | $39,032,821 | 1 | Feb 23, 2023 | sec.gov | |
| Apr 23, 2015 | New notice | Indefinite | $60,000,003 | 10 | Apr 9, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James A. Geraghty | Director | |
| Grace A. Colon | Director | |
| Glenn A. Pierce | Director | |
| Steven A. Hyman | Director | |
| George A. Scangos | Director | |
| Peter Pfreundschuh | Executive Officer | |
| Jacquelyn Fahey Sandell | Executive Officer | |
| Nancy A. Vitale | Director | |
| Alfred Sandrock | Executive Officer, Director | |
| Michael Higgins | Director | |
| Robin Swartz | Executive Officer | |
| Jude A. Onyia | Director | |
| Catherine A. Mackey | Director | |
| Todd Carter | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Voyager Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.